Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report.
Haffen
E
E
Vandel
P
P
Bonin
B
B
Vandel
S
S
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000493:pharmacokinetics*; D015283:Citalopram / Q000493:pharmacokinetics*; D002997:Clomipramine / Q000493:pharmacokinetics*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004351:Drug Resistance; D005260:Female; D005838:Genotype; D014453:Glucuronosyltransferase / Q000037:antagonists & inhibitors*; D006801:Humans; D008658:Inactivation, Metabolic; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics*
D000929:Antidepressive Agents, Tricyclic; D015283:Citalopram; D002997:Clomipramine; D019389:Cytochrome P-450 CYP2D6; D014453:Glucuronosyltransferase; D017367:Selective Serotonin Reuptake Inhibitors